Ono and Macomics join forces to develop cancer therapy The partnership will involve progressing macrophage-targeting antibody treatment for cancer... openexo.com/feed/item/ono-… #BioTech #science

BetaLife and A*STAR Agree to Focus on Novel Cell-Based Therapy for Diabetes BetaLife, a stem cell therapy company working on regenerative medicine for diabetes, acquired the rights to human induced Pluripotent S... openexo.com/feed/item/beta… #BioTech #science

Neutrophils Found to Be Culprits in Treatment-Resistant Pancreatic Cancer Researchers led by Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown for the first ... openexo.com/feed/item/neut… #BioTech #science

Common Genetic Signature May Increase Risk of Multiple Substance Abuse Disorders The results of NIH-funded research suggest that a common genetic signature may increase an individual’s risk of developing substance us... openexo.com/feed/item/comm… #BioTech #science

Human Fasting Modulates Macrophage Function The Journal Club returns on Tuesday 28th March at 12:00 PM Eastern time to the Lifespan.io Facebook channel. This month Dr. Oliver Medv... openexo.com/feed/item/huma… #BioTech #science

Wesper gets FDA nod for next-generation sleep care device The new device will gather significant clinical-grade longitudinal data to diagnose and monitor treatment efficacy over time... openexo.com/feed/item/wesp… #BioTech #science

Rhisa and Gradient Health data tie-up aims to accelerate innovation Medical technology companies Rhisa and Gradient Health join forces to accelerate healthcare innovation by providing a new scale of dive... openexo.com/feed/item/rhis… #BioTech #science

Hamamatsu beings construction of new Japan-based facility Hamamatsu Photonics will start the construction of a new factory building to meet the growing demand of the opto-semiconductor device m... openexo.com/feed/item/hama… #BioTech #science

ThoughtFull gets $4M funding from Temasek's Sheares, other tech founders It also received backing from the founders of Grab and Zalora.... openexo.com/feed/item/thou… #BioTech #science

Blood for money: my journey in the industry buying poor Americans plasma The US is one of the few countries that allows donors – who are often struggling economically – to be paid for plasmaI was sitting in t... openexo.com/feed/item/bloo… #BioTech #science

How would US health and government officials have handled COVID if we knew then what we know now? ... openexo.com/feed/item/how-… #BioTech #science

Algae contains high levels of protein and nutrients. Could it help boost food security in the face of climate change? ... openexo.com/feed/item/alga… #BioTech #science

Infusing beans with a new genetic blueprint: Synthetic biology startup engineers soybeans to produce ingredients for cancer drugs, vaccines and infant formula ... openexo.com/feed/item/infu… #BioTech #science

Tofersen panel bolsters case for neurofilament as ALS surrogate endpoint REGULATIONTOFERSEN PANEL BOLSTERS CASE FOR NEUROFILAMENT AS ALS SURROGATE ENDPOINT BY FDA advisory committee backs accelerated approval... openexo.com/feed/item/tofe… #BioTech #science

New CFOs at Remix, Capstan MANAGEMENT TRACKSNEW CFOS AT REMIX, CAPSTANBY Plus: Maderis to be chair at Durect and updates from Generate and Patient Discovery Solut... openexo.com/feed/item/new-… #BioTech #science

EpiBiologics tapping two lysosomal degradation mechanisms with $50M EMERGING COMPANY PROFILEEPIBIOLOGICS TAPPING TWO LYSOSOMAL DEGRADATION MECHANISMS WITH $50M BY The UCSF spinout is degrading membrane-b... openexo.com/feed/item/epib… #BioTech #science

March 22 Quick Takes: GordonMD,Pfizer Ventures lead Flares $123M B round QUICK TAKES: GORDONMD, PFIZER VENTURES LEAD FLARE’S $123M B ROUND BY Plus: FDA approvals for Cidara, Incyte and updates from Karuna, As... openexo.com/feed/item/marc… #BioTech #science

Genomadix Gets FDA 510(k) Clearance for Point-of-Care PCR System, CYP2C19 Test Formerly known as Spartan Bioscience, Ottawa, Canada-based Genomadix expects to now commercialize the system and test in the US to guid... openexo.com/feed/item/geno… #BioTech #science

How 89bios Phase IIb NASH data match up with Akeros in FGF21 class DATA BYTE HOW 89 BIO’S PHASE IIB NASH DATA MATCH UP WITH AKERO’S IN FGF21 CLASSBY Planned Phase III trials would clarify benefit compar... openexo.com/feed/item/how-… #BioTech #science

Rising Rate of Drug Shortages Is Framed as a National Security Threat A Senate homeland security committee examined growing health care shortages amid reports of rationing within hospitals.... openexo.com/feed/item/risi… #BioTech #science